These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7166673)

  • 1. [2 cases of nonspecific multiple ulcers of the small intestine associated with osteomalacia caused by long-term intravenous administration of saccharated ferric oxide].
    Okada M; Imamura K; Fuchigami T; Omae T; Iida M; Nanishi F; Murakami M; Ohgushi H; Yao T; Fujita K; Ogawa K
    Nihon Naika Gakkai Zasshi; 1982 Nov; 71(11):1566-72. PubMed ID: 7166673
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia.
    Shimizu Y; Tada Y; Yamauchi M; Okamoto T; Suzuki H; Ito N; Fukumoto S; Sugimoto T; Fujita T
    Bone; 2009 Oct; 45(4):814-6. PubMed ID: 19555782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case of osteomalacia due to intravenous saccharated ferric oxide].
    Nakaoka T; Sugimoto T; Okimura Y; Chihara K
    Nihon Naika Gakkai Zasshi; 1998 Jul; 87(7):1372-3. PubMed ID: 9745288
    [No Abstract]   [Full Text] [Related]  

  • 4. Iatrogenic osteomalacia caused by intravenous administration of saccharated ferric oxide.
    Suzuki A; Ohoike H; Matsuoka Y; Irimajiri S
    Am J Hematol; 1993 May; 43(1):75-6. PubMed ID: 8317471
    [No Abstract]   [Full Text] [Related]  

  • 5. [Case report; A case of FGF23-related hypophosphatemic osteomalacia caused by long-term administration of saccharated ferric oxide].
    Wada Y; Kinoshita Y; Taguchi M; Fukumoto S; Fujita T
    Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):3031-3. PubMed ID: 22175146
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypophosphatemia induced by intravenous administration of Saccharated iron oxide.
    Okada M; Imamura K; Iida M; Fuchigami T; Omae T
    Klin Wochenschr; 1983 Jan; 61(2):99-102. PubMed ID: 6843038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide.
    Yamamoto S; Okada Y; Mori H; Fukumoto S; Tanaka Y
    Intern Med; 2012; 51(17):2375-8. PubMed ID: 22975552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of hypophosphatemia induced by intravenous administration of saccharated iron oxide].
    Konjiki O; Fukaya S; Kanou H; Imamura T; Iwamoto T; Takasaki M
    Nihon Ronen Igakkai Zasshi; 1994 Oct; 31(10):805-10. PubMed ID: 7853746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone and Nutrition. The relationship between iron and phosphate metabolism].
    Takashi Y; Fukumoto S
    Clin Calcium; 2015 Jul; 25(7):1037-42. PubMed ID: 26119317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections.
    Macdougall IC; Roche A
    Am J Kidney Dis; 2005 Aug; 46(2):283-9. PubMed ID: 16112047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of osteomalacia due to deranged mineral balance caused by saccharated ferric oxide and short-bowel syndrome: A case report.
    Nomoto H; Miyoshi H; Nakamura A; Nagai S; Kitao N; Shimizu C; Atsumi T
    Medicine (Baltimore); 2017 Sep; 96(39):e8147. PubMed ID: 28953654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Simple ulcers of the small intestine as a cause of peritonitis].
    Baulin NA
    Khirurgiia (Mosk); 1977; (4):115-9. PubMed ID: 853640
    [No Abstract]   [Full Text] [Related]  

  • 13. Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy.
    Sato K; Shiraki M
    Endocr J; 1998 Aug; 45(4):431-9. PubMed ID: 9881891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia.
    Schouten BJ; Doogue MP; Soule SG; Hunt PJ
    Ann Clin Biochem; 2009 Mar; 46(Pt 2):167-9. PubMed ID: 19151167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron therapy by intravenous infusion of saccharated iron oxide.
    Efstratopoulos AD; Tountas CD; Merikas GE; Komninos Z
    Br J Clin Pract; 1973 Apr; 27(4):133-5. PubMed ID: 4761128
    [No Abstract]   [Full Text] [Related]  

  • 16. Stenosing ulcers of the small bowel associated with thiazide and potassium therapy.
    Holland GW
    N Z Med J; 1965 Jul; 64(395):383-5. PubMed ID: 5213040
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug-induced osteomalacia].
    Sato K
    Clin Calcium; 2007 Oct; 17(10):1536-42. PubMed ID: 17906405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the intravenous iron preparation Ferrlecit].
    Słomkowski M; Maj S
    Acta Haematol Pol; 1983; 14(1):49-53. PubMed ID: 6351527
    [No Abstract]   [Full Text] [Related]  

  • 19. Uncommon adverse effect of a common medication.
    Moore KL; Kildahl-Andersen O; Kildahl-Andersen R; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2013 Jan; 133(2):165. PubMed ID: 23344600
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary nonspecific small bowel ulceration as a source of chronic bleeding. Report of a case and review of the approach to localization of the site of small bowel hemorrhage.
    Graham DY; Bynum TE
    Am J Gastroenterol; 1974 Oct; 62(4):350-5. PubMed ID: 4547913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.